AB SCIEX has marked the next major
phase of its expansion in Singapore
with the opening of a new research and
development (R&D) centre. The facility is
an extension of the company’s $10-million
global operations in Marsiling where
life science industry-leading analytical
instruments, including the AB SCIEX
6500 series and TripleTOF series, are
manufactured.
AB SCIEX’s R&D Centre in Singapore
– its fi rst outside North America – will be
focused on new product development,
VAVE (value added value engineering), and
quality improvement, and brings R&D and
manufacturing closer together. The company
has also invested in an application support and training facility in
Biopolis, Singapore’s state-of-theart biomedical research hub housing a
community of public and private researchers.
The new R&D Centre rides on the success of AB SCIEX’s global manufacturing facility that was set up
in Singapore in 2007, and the subsequent establishment of its headquarter functions here, including
its supply chain and logistics operations.
|
 |